On April 16 (local time), U.S.-based OpenAI announced a new AI system called 「GPT-Rosalind」—a reasoning モデル (moderu, model) specialized in life sciences. The goal: speed up drug discovery and support advanced biological research.

A Model Specialized in Life Sciences

OpenAI introduced GPT-Rosalind as a model 生命科学分野に特化した (seimei kagaku bun’ya ni tokka shita)—“specialized in the field of life sciences.” It was developed to support research in biology, drug discovery, and translational medicine.

According to the company, the model enhances understanding in:

• Chemistry
• Protein engineering
• Genomics

It also improves the ability to use scientific research tools effectively.

OpenAI explains that from identifying a potential drug target to receiving regulatory approval in the United States, the process typically takes 10 to 15 years. If researchers can improve the quality of target selection, hypothesis development, and experiments in the early stages, those improvements can positively affect the entire pipeline.

However, life sciences research requires navigating enormous volumes of academic papers, specialized databases, experimental data, and competing hypotheses. This process can be time-consuming and fragmented. By using AI to integrate literature and evidence, generate hypotheses, and design experiments across multiple stages, OpenAI aims to accelerate early discovery.

In Japanese news writing, you’ll often see phrases like:

• 〜と発表した (to happyō shita) — “announced that…”
• 〜と説明する (to setsumei suru) — “explains that…”

These expressions are standard for reporting what a company or official said.

What GPT-Rosalind Can Do

OpenAI lists several expected applications:

• Cross-domain reasoning across molecules, proteins, genes, pathways, and disease-related biology
• Literature review
• Interpreting function from biological sequences
• Experimental design
• Data analysis

In addition, the company released a free 「Life Sciences research plugin」 for Codex. A プラグイン (puraguin, plugin) is a software extension that adds new functions to an existing system. This one connects to more than 50 scientific tools and data sources.

It supports areas such as:

• Human genetics
• Functional genomics
• Protein structure
• Biochemistry
• Clinical evidence
• Public research databases

GPT-Rosalind will be available through ChatGPT, Codex, and the API (ē pī ai), as a research プレビュー (purebyuu, preview). During the preview period, it will not consume existing credits or トークン (tōkun, tokens — units used to measure AI usage). However, guardrails will be implemented to prevent misuse.

Strict Controls and “Trusted Access”

Because life sciences research can directly impact human lives, OpenAI says it is taking steps to prevent accidents or biological misuse.

The model will be provided through 「Trusted Access for Cyber（TAC）」, initially limited to qualified corporate customers in the United States. The company will implement strict controls related to eligibility and ガバナンス (gabanansu, governance) and コンプライアンス (konpuraiansu, compliance — adherence to laws and regulations).

Participating organizations must:

• Demonstrate clear public benefit
• Conduct appropriate scientific research
• Maintain proper governance and misuse-prevention controls
• Operate in secure environments limited to approved users

Enhanced security and access management will also be applied, and additional information may be required when necessary.

The Name “Rosalind”

The model’s name comes from Rosalind Franklin, the British scientist who contributed to uncovering the structure of DNA and helped lay the foundation of modern molecular biology.

Naming advanced AI systems after pioneering scientists is a way of connecting cutting-edge technology with the history of scientific discovery.

Meanwhile, competitor Anthropic announced in January that it had expanded its offerings of “Claude” for the medical and life sciences fields—showing that AI for healthcare and research is becoming an increasingly competitive area.

Learn Japanese from This Article

Vocabulary

Notice how many of these are loanwords written in katakana. In technology and business news, this is extremely common in modern Japanese.

Grammar Spotlight

1️⃣ 〜に特化した — “specialized in”

Structure: Noun + に特化した

This pattern describes something designed or focused specifically on one area.

Example from the article:

• 生命科学分野に特化したモデル Seimei kagaku bun’ya ni tokka shita moderu A model specialized in the field of life sciences

More examples:

• 医療に特化したAI Iryō ni tokka shita AI An AI specialized in medicine

• 教育分野に特化したサービス Kyōiku bun’ya ni tokka shita sābisu A service focused on education

This pattern is extremely useful in business and tech contexts.

2️⃣ 〜と発表した／〜と説明する — Reported Speech

Japanese news articles frequently use:

• 〜と発表した — announced that…
• 〜と説明する — explains that…

Example:

• OpenAIは新モデルを発表した。 OpenAI wa shin moderu o happyō shita. OpenAI announced a new model.

Unlike English, Japanese doesn’t always require quotation marks. The particle と marks the content being reported.

Useful Expression

• 研究プレビューとして提供する Kenkyū purebyuu to shite teikyō suru To provide (something) as a research preview

This structure—〜として (to shite, “as”)—is another very common and useful pattern.

Continue Learning

Curious about how dates like “4月16日” are used without clear tense markers in Japanese news?

• Time and Dates: Tense-Free Expressions: Curious about the Japanese used here? Our Time and Dates: Tense-Free Expressions lesson covers this in depth.

AI is rapidly entering fields once thought too complex or sensitive for automation. By understanding the Japanese used to report these developments, you’re not just learning vocabulary—you’re gaining access to how Japan discusses science, responsibility, and innovation.

これからもよろしくお願いします。 Kore kara mo yoroshiku onegaishimasu.